CDKN1A and metabolic dysfunction-associated steatotic liver disease: Similar findings have also been demonstrated in alcoholic liver disease, the histopathology of which is virtually indistinguishable from NAFLD, with increased p21 expression being strongly associated with fibrosis stage and adverse clinical outcomes [159].